Protease gene analysis of HIV type 1 non-B subtypes in Spain

AIDS Research and Human Retroviruses

Volumn 16, Issue 14, 2000, Pages 1395-1403

  Holguin, A ^a   Rodes, B ^a   Soriano, V ^a  

^a HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; PROTEINASE; RITONAVIR; STAVUDINE; VIRUS RNA; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; LYMPHOCYTE COUNT; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SPAIN; VIREMIA; VIRUS ISOLATION; VIRUS LOAD; VIRUS TYPING;

ADULT; AMINO ACID SUBSTITUTION; DRUG RESISTANCE, MICROBIAL; FEMALE; GENES, VIRAL; HIV INFECTIONS; HIV PROTEASE; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SPAIN; VIRAL LOAD; VIREMIA;

EID: 0034692558     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220050140946     Document Type: Article

References (49)

1. HIV population dynamic in vivo: Implications for genetic variation, pathogenesis, and therapy
2. HIV-1 genetic diversity
3. Recombination in HIV-1: Update and implications
4. Geographical distribution of HIV-1 group O viruses in Africa
5. Identification of a new HIV-1 distinct from group M and group O
6. Syncytium-inducing capacity of HIV type 1 subtypes other than B: Phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization
7. Macrophage-tropism of HIV-1 isolates of different genetic subtypes
8. Biological phenotypes of HIV-1 subtypes A and B strain of diverse origins
9. Human immunodeficiency virus type 1 subtypes differ in disease progression
10. Increase of HIV-1 subtype A in Central African Republic
11. Subtypes of HIV type 1 and disease stage among women in Nairobi, Kenya
12. Divergent transcriptional regulation among expanding HIV type 1 subtypes
13. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
14. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients
15. Subtype-specific problems with quantification of plasma HIV-1 RNA
16. HIV type1 sequence subtype G transmission from mother to infant: Failure of variant sequence species to amplify in the Roche Amplicor test
17. Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV-1 type 1 subtype G strain
18. Comparison of branched DNA and reverse transcriptase polymerase chain reaction for quantifying six different HIV-1 subtypes in plasma
19. Comparison of three commercial methods for quantification of plasma viraemia in clinical specimens belonging to non-B subtypes
20. Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors
21. Drug susceptibility of subtypes A, B, C, D, and E human immunodeficiency virus type 1 primary isolates
22. Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: Generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E
23. The HIV-1 V3 domain on field isolates: Participation in generation of escape virus in vivo and accessibility to neutralizing antibodies
24. HIV-1 type 1 V3 serotyping of Tanzanian samples Probable reasons for mismatching with genetic subtyping
25. Lack of correlation between V3-loop peptide enzyme immunoassay serologic subtyping and genetic sequencing
26. Rapid characterization of HIV type I strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV isolation and characterization
27. Genetic relationships determined by a DNA heteroduplex mobility assay: Analysis of HIV-1 env genes
28. Identification of single and duel infections with distinct subtypes of HIV type 1 by using restriction fragment length polymorphism analysis
29. Human immunodeficiency viruses type I subtypes circulating in Spain
30. A Comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of HIV type 1
31. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
32. The neighbor-joining method: A new method for reconstructuring phylogenetic trees
33. Quartet puzzling: A quartet maximum likelihood method for reconstructuring tree topologies
34. An-enhanced-sensitivity branched-DNA assay for quantification of HIV-1 RNa in plasma
35. Quantification of HIV-1 RNA in plasma using NASBA during primary HIV-1 infection
36. Rapid and simple PCR assay for quantitation of HIV-1 RNA: Application to acute retroviral infection
37. Full genome sequences of HIV type 1 subtypes G and A/G intersubtypes recombinants
38. Use of changes in plasma levels of HIV type 1 RNA to assess the clinical benefit of antiretroviral therapy
39. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma
40. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes
41. Introduction of drug resistance testing in clinical practice
42. Full-length genomic sequence of an HIV type 1 subtype G from Kinshasa
43. Variations in HIV-1 pol gene associated with reduced sensitivity to antiretroviral drugs in treatmentnaive patients
44. Identification of HIV-1 envelopes genes recombinant between subtypes B and F in two epidemiologically linked individuals from Brazil
45. Identification of HIV-1 subtype G from Uganda
46. Biological and molecular characterization of subtype D, G and A/D recombinant HIV-1 transmission in Sweden
47. Subtype G and multiple forms of A/G intersubtype recombinant HIV type 1 in Nigeria